As new device identification and traceability measures become compulsory in 2020, under the new EU Medical Device Regulation, this white paper explores the residual issues that remain for manufacturers, especially with regard to global labelling management. How might they overcome these challenges effectively - so that they do not fall foul of the new requirements, and so that they are better prepared next time regulatory changes are brought in?
